CV Outcomes following Treatment with MK3102 in Subjects with T2DM

• Research type

  Research Study

• Full title

  A Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus

• IRAS ID

  123524

• Contact name

  Stephen Bain

• Contact email

  S.C.Bain@swansea.ac.uk

• Sponsor organisation

  Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

• Eudract number

  2012-002414-39

• ISRCTN Number

  -

• Clinicaltrials.gov Identifier

  -

• REC name

  Wales REC 3

• REC reference

  13/WA/0084

• Date of REC Opinion

  1 Aug 2013

• REC opinion

  Further Information Favourable Opinion